Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dominic Smethurst

Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed April 7, 2026 that Dominic Smethurst resigned as Chief Medical Officer, effective June 30, 2026. The proxy statement of Corbus Pharmaceuticals Holdings, Inc. reports total compensation of $1,800,142 for Dominic Smethurst in fiscal 2025, including a base salary of $519,313. Disclosed compensation is on record for 3 fiscal years.

“On April 1, 2026, Corbus Pharmaceuticals Holdings, Inc. (the “Company”) was notified by Dominic Smethurst, the Company’s Chief Medical Officer, of his resignation, effective June 30, 2026.”
Corbus Pharmaceuticals Holdings, Inc. Form 8-K, filed April 7, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Corbus Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $519,313 $1,800,142
2024 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $408,914 $2,892,972
2023 Corbus Pharmaceuticals Holdings, Inc. (CRBP) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.